Interestingly, according to several clinical trials, a high level of TUBB3 is associated with negativity for estrogen and progesterone receptors in breast cancer patients[72,73] and, as a result, with worse disease-free and overall survival[73,74]. This evidence concerns the gene PGR and breast cancer.